GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $846,000 | +20.2% | 26,472 | -4.2% | 0.01% | 0.0% |
| Q3 2021 | $704,000 | +49.2% | 27,623 | +138.7% | 0.01% | +42.9% |
| Q1 2021 | $472,000 | -86.9% | 11,571 | -82.4% | 0.01% | -90.3% |
| Q3 2020 | $3,616,000 | -43.8% | 65,587 | -35.7% | 0.07% | -56.9% |
| Q2 2020 | $6,439,000 | +2395.7% | 101,992 | +1918.4% | 0.17% | +1092.9% |
| Q1 2020 | $258,000 | +9.8% | 5,053 | +13.0% | 0.01% | +55.6% |
| Q2 2019 | $235,000 | – | 4,473 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 106,684 | $4,379,000 | 12.10% |
| Fernwood Investment Management, LLC | 357,212 | $14,664,000 | 9.45% |
| Perceptive Advisors | 5,425,726 | $222,726,000 | 8.48% |
| GREAT POINT PARTNERS LLC | 1,180,000 | $48,439,000 | 6.12% |
| Camber Capital Management LP | 2,250,000 | $92,363,000 | 4.38% |
| NEXTHERA CAPITAL LP | 221,662 | $9,099,000 | 3.75% |
| Boxer Capital, LLC | 700,000 | $28,735,000 | 3.55% |
| Casdin Capital, LLC | 350,000 | $14,368,000 | 2.46% |
| MAK CAPITAL ONE LLC | 96,040 | $3,942,000 | 2.14% |
| EMORY UNIVERSITY | 62,643 | $2,571,000 | 2.03% |